Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review.

"Conflict of interest statement: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: MH has received consulting fees from Alkermes. The authors have no other conflicts to declare."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: RS is supported by Bebensee Schizophrenia Research Fellowship, by the Ian Douglas Bebensee Foundation, Toronto, Canada. JL is supported by the Ontario Graduate Scholarship. MH holds the Meighen Family Chair in Psychosis Prevention and the Cardy Schizophrenia Research Chair and is funded by operating grants from CIHR (grant nos. PJT-201610 and PJT-201909), the Danish Diabetes Academy, a Steno Diabetes Centre Fellowship, the BBDC, and the PSI Foundation. SMA is supported by in part by an Academic Scholars Award from the Department of Psychiatry, University of Toronto and the CAMH Discovery Fund, and has operating grants from the Canadian Institutes of Health Research (PJT-201909), PSI foundation, the CAMH Discovery Fund."